NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients
Reem Hal/LinkedIn
Dec 25, 2025, 23:39

Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients

Reem Hal, Senior Pediatric Oncology Clinical Pharmacist at Borg El Arab Main University Hospital, shared a post on LinkedIn:

“Clinical Capsule | Oncology Rounds

Capsule #5 – Thrombosis in Cancer Patients

‘The cancer didn’t cause the ICU admission — the missed prophylaxis did.’

A patient with multiple myeloma on
lenalidomide + dexamethasone
missed thromboprophylaxis →
acute myocardial infarction. ICU admission.

Clinical Pearl
IMiD-based regimens dramatically increase thrombotic risk.

Standard practice

  • Low risk → Aspirin
  • High risk → LMWH or DOAC

Missed prophylaxis may lead to

  • MI or stroke
  • Treatment interruption

Take-home message
In multiple myeloma, thromboprophylaxis is not optional — it is life-saving.”

Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients

Follow the latest in Hemostasis Today.

Clinical Capsule Dexamethasone Health Hemostasis Hemostasis Today lenalidomide Medicine Myeloma Oncology Reem Hal thrombosis Thrombotic Risk
NewsFeed